Member Profile

Lumosa Therapeutics (Lumosa) is dedicated to the development of innovative new drugs for the treatment of unmet medical needs in the fields of neurological and inflammatory diseases. Lumosa is actively engaged in scientific licensing and new drugs development under a “reSEARCH and DEVELOPMENT” model. Through its expertise in translational research, project management, patent management and licensing strategy, the Company plans for product lifecycle management at the inception of the projects, optimizes the development process and maximizes the value of its products for out-licensing. Lumosa team boasts extensive experience across the entire spectrum of drug development, including in vitro & in vivo pharmacology, CMC, preclinical, clinical development, project management, regulatory affairs, intellectual property and business development. By leveraging a highly specialized division of labor and robust project management techniques, Lumosa efficiently develops internationally competitive drugs with significant market potential. The Company’s ultimate goal is to forge strategic alliances and secure technology licensing agreements targeting the global market, positioning Lumosa Therapeutics as a key player in addressing unmet medical needs worldwide.